Drawing for INDUCTIUM

USPTO serial 99429529

INDUCTIUM

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SEGAL, MOLLY DANIELA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with INDUCTIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances for the treatment and prevention of bone and tissue diseases and disorders, musculoskeletal diseases and disorders, blood vessel diseases and damage, craniomaxillofacial diseases and damage, skin diseases and damage, bone and joint injuries, spinal injuries, and cancerACTIVE—
010Metal parts and fittings of implantable medical devices coated with recombinant proteins; metal parts and fittings of bone regeneration matrices coated with recombinant proteins; metal parts and fittings of soft tissue regeneration matrices coated with recombinant proteins; metal parts and fittings of medical and surgical devices, apparatus, and instruments coated with recombinant proteins for use in bone, spine, and joint surgery, regeneration, reconstruction, and augmentation; metal parts and fittings of bone implants coated with recombinant proteinsACTIVE—
042Research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, joint repair, osteochondral repair, spinal fusion, spinal repair, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; scientific research and development; research and development of medical devices, apparatus, and implants for use in vascular repair, orthopedic repair, bone repair, joint repair, osteochondral repair, spinal fusion, spinal repair, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
May 19, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 24, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 6, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance